NCT03511196 2025-12-04
Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Active not recruiting
Clinical Trials
13 trialsNCT07159906 2025-09-08
Homoharringtonine, BCL-2 Inhibitor, Rituximab, and Prednisone in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
First Affiliated Hospital of Zhejiang University
Phase 1/2 Not yet recruiting
NCT04025840 2025-07-31
Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery
Peking University First Hospital
Phase 4 Active not recruiting
NCT04209218 2025-07-31
Intraoperative Blood Pressure Management and Dexamethasone in Lung Cancer Surgery
Peking University First Hospital
Phase NA Recruiting
NCT04042220 2024-01-05
Glucocorticoids, Immunotherapy and Radiosurgery for Brain Metastases
Medical University of Vienna
Completed
NCT05855395 2023-07-12
The Standard of Care Combined With Glucocorticoid in Elderly People With Mild or Moderate COVID-19
Huashan Hospital
Phase NA Unknown
NCT02167633 2021-03-11
Stereocord
Rigshospitalet, Denmark
Phase NA Terminated
NCT01576588 2019-12-27
Rituximab in Pretreated Elderly or Unfit B-CLL Patients
Vilnius University
Phase 2 Completed
NCT00805207 2018-08-01
SCOR
Washington University School of Medicine
Phase NA Completed
NCT00201812 2017-12-06
Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid Tumors
Ohio State University Comprehensive Cancer Center
Phase 1 Completed
NCT02878161 2016-08-25
Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"
Central South University
Phase 4 Unknown
NCT00474383 2014-05-12
An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy
Cougar Biotechnology, Inc.
Phase 2 Completed
NCT01664728 2013-04-19
An Expanded Access Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Have Completed Clinical Study COU-AA-001
Janssen Research & Development, LLC
Phase 1 Completed